Table 2.

Patient characteristics at entry into the study


Characteristic

No.
Number of patients; male:female   236; 124:112  
Age, y, male:female   
    0 to 4   152; 79:73  
    5 to 9   66; 40:26  
    Older than 9   18; 5:13  
    Median age, mo   35  
Hemoglobin level, g/L, mean±SD   78±11  
Hematocrit level, proportion of 1, mean±SD   .252±.037  
Reticulocyte count, proportion of 1, mean±SD   .118±.065  
Patients characterized for fetal hemoglobin   131  
    Male, %, mean±SD, n = 74   10.1±5.8  
    Female, %, mean±SD, n = 57   11.9±5.8  
Patients characterized for βs haplotype   118  
    Homozygous Benin/Benin   108  
    Heterozygous or atypical   10  
Patients characterized for α-globin gene status   117  
    αα/αα   62  
    αα/α-   48  
    α-/α-   7  
Patients characterized for G6PD variant A   107  
    Male (patients with A-)   89 (17)  
    Female (patients with A-)
 
18 (8*)
 

Characteristic

No.
Number of patients; male:female   236; 124:112  
Age, y, male:female   
    0 to 4   152; 79:73  
    5 to 9   66; 40:26  
    Older than 9   18; 5:13  
    Median age, mo   35  
Hemoglobin level, g/L, mean±SD   78±11  
Hematocrit level, proportion of 1, mean±SD   .252±.037  
Reticulocyte count, proportion of 1, mean±SD   .118±.065  
Patients characterized for fetal hemoglobin   131  
    Male, %, mean±SD, n = 74   10.1±5.8  
    Female, %, mean±SD, n = 57   11.9±5.8  
Patients characterized for βs haplotype   118  
    Homozygous Benin/Benin   108  
    Heterozygous or atypical   10  
Patients characterized for α-globin gene status   117  
    αα/αα   62  
    αα/α-   48  
    α-/α-   7  
Patients characterized for G6PD variant A   107  
    Male (patients with A-)   89 (17)  
    Female (patients with A-)
 
18 (8*)
 
*

One female patient was homozygous A-/A-

Close Modal

or Create an Account

Close Modal
Close Modal